ICS: Life-changing launch
By ICS Connect
To launch an orphan drug, a manufacturer must overcome unique commercialization challenges, while navigating critical product access scenarios that exist most acutely for small patient populations. Read how one manufacturer ensured that its life-changing therapy would reach patients in need the moment it was first available—and what other manufacturers can learn from this manufacturer’s experiences.
To get manufacturer perspectives on maximizing success for orphan drug commercialization, click below to download the full presentation.
